98 
Ethical and Policy Developments 
ENDNOTES 
' "Press Conference by President Bush and Italian Prime Minister Berlusconi," as made 
available by the White House Press Office, July 23, 2001. 
^ See, for instance, Weissman, I. L., "Stem Cells — Scientific, Medical and Political Is- 
sues," New England Journal of Medicine 346(20): 1576-1579 (2002). 
^ See, for instance. Green, R., "Determining Moral Status," American Journal of Bio- 
ethics 2{1): 28-29 (2002). 
^ See, for instance, Orr, R., "The Moral Status of the Embryonal Stem Cell: Inherent or 
Imputed?" American Journal of Bioethics 2{1): 57-59 (2002). 
® See, for instance, Doerflinger, R., "Ditching Religion and Reality," American Journal of 
Bioethics 2{1): 31 (2002). 
® See, for instance, Latham, S., "Ethics and Politics,” American Journal of Bioethics 
2(1): 46 (2002). 
’ See, for instance, Mcirquis, D., "Stem cell research: The Failure of Bioethics," Free 
Inquiry 22(1): Winter 2002. 
® See, for instance, the presentation of Richard Doerflinger before the Council on June 
12, 2003. A transcript of that presentation is available on the Council website at 
www.bioethics.gov. 
® See, for instance, FitzGerald, K., "Questions Concerning the Current Stem Cell De- 
bate," American Journal of Bioethics 2(1): 50-51 (2002). 
See, for instance, Haseltine, W., "Regenerative Medicine: A Future Healing Art," 
Brookings Review, Winter 2003. 
" See, for instance, Stolberg, S., "Scientists Urge Bigger Supply of Stem Cells," The 
New York Times, September 11, 2001, p. Al. 
See, for instance. Perry, D., "Patients’ Voices: The Powerful Sound in the Stem Cell 
Debate," Science 287: 5457, 1423; and the presentation of Irving Weissman before the 
Council on February 13, 2002, available on the Council website at www.bioethics.gov. 
This point was taken up by the Council in its report Human Cloning and Human 
Dignity: An Ethical Inquiry (July 2002), Chapter 6, pp. 167-168. 
One useful description of this approach to the issue is Zoloth, L., “Jordan’s Banks, A 
View from the First Years of Human Embryonic Stem Cell Research," American Journal 
of Bioethics 2{1): 7 (2002). 
Callahan, D., What Price Better Health: The Hazards of the Research Imperative. Los 
Angeles, CA.: University of California Press, 2003; also see Daniel Callahan’s presenta- 
tion before the Council on July 24, 2003, available on the Council’s website at 
www.bioethics.gov. 
FitzGerald, K., op, cit., pp. 50-51. 
PRE-PUBLICATION VERSION 
